BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Factor Xa

Download PDF PDF Version

Image Results

Loading...

Recent Publications on Factor Xa:

Pubmed Logo
Comparative effects of atrial polypeptide and neurohormone C on the interaction of factor Xa with antithrombin III.
The effects of atrial polypeptide and neurohormone C upon the interaction...
4th October, 2008
aDepartment of Biological Sciences, USA bDepartment of Chemistry, Bowling Blood Coagul Fibrinolysis. 2008 Oct;19(7):645-51.
DOI Direct Link
APIXABAN METABOLISM AND PHARMACOKINETICS FOLLOWING ORAL ADMINISTRATION TO HUMANS.
The metabolism and disposition of [(14)C]apixaban, an orally bioavailable,...
4th October, 2008
Bristol-Myers Squibb. Drug Metab Dispos. 2008 Oct 2.
DOI Direct Link
Prevention of venous thromboembolism in hospitalized medical patients.
The hospitalized medical patient in the US today has multiple risk factors...
2nd October, 2008
Division of Hospital Medicine, University of Miami, Miller School of Mt Sinai J Med. 2008 Sep 30;75(5):449-453.
DOI Direct Link
Anti-factor Xa Plasma Levels in Pregnant Women Receiving Low Molecular Weight Heparin Thromboprophylaxis.
OBJECTIVE: To report the incidence of prophylactic, subprophylactic, and...
2nd October, 2008
Maternal Fetal Medicine Associates, PLLC, and the Department of Obstet Gynecol. 2008 Oct;112(4):884-889.
DOI Direct Link
Differential Effects of Factor IIa Inhibitors on the Endogenous Thrombin Potential.
ABSTRACT:: Calibrated automated thrombin generation measurement in...
1st October, 2008
From the *Institut fur Pharmakologie, Universitat Duisburg-Essen, Ther Drug Monit. 2008 Sep 26.
DOI Direct Link

View more research publications.

BioNews Results for Factor Xa:

RSS Logo
BioPortfolio Logo
Bayer's Novel Oral Anticoagulant Xarelto (Rivaroxaban) Gets European Licence
Drugs.com:  Oct 3 2008 7:34AM Matching: factor xa
Bayer's Novel Oral Anticoagulant Xarelto (Rivaroxaban) Gets European Licence
Pharma Live:  Oct 3 2008 5:42AM Matching: factor xa
Apixaban Metabolism And Pharmacokinetics Following Oral Administration To Humans
Drug Metabolism And Disposition:  Oct 3 2008 1:53AM Matching: factor xa
Bayer wins European approval for Xarelto pill
Reuters Health:  Oct 2 2008 12:40AM Matching: factor xa
UPDATE 1-Bayer wins European approval for Xarelto pill
Forbes.com:  Oct 1 2008 4:59PM Matching: factor xa
Promote your company here: BioNewsCast - Press Release Distribution

View more news.

Factor Xa Clinical Trials:

Clinical Trials Logo
Factor Xa Inhibitor for Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement
Thromboembolism Interventions: Drug: YM150;   Drug: enoxaparin

Factor Xa Patents:

USPTO Logo
US Patent No.Title
7422848 Hepatitis-B viral variants with reduced susceptibility to nucleoside analogs and uses thereof
7425531 Bone polypeptide-1
7425539 Factor IXa for the treatment of bleeding disorders
7425550 Lactam glycogen phosphorylase inhibitors and method of use
7425576 Compounds as inhibitors of hepatitis C virus NS3 serine protease

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Factor Xa scientists - we have details of around 485 individuals working on Factor Xa .


This page has been viewed 143 times
Recent Search Terms used to find this page: activated factor x appraise | activated factor x appraise | defensin 5 | pd-0348292 press release | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Factor Xa across BioPortfolio, or bestselling Factor Xa books or recently published Factor Xa books .
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional